HOTH (Hoth Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades
Hoth Therapeutics, Inc. Common Stock (HOTH) is a publicly traded Healthcare sector company. As of May 21, 2026, HOTH trades at $0.60 with a market cap of $11.72M and a P/E ratio of -0.66. HOTH moved +0.10% today. Year to date, HOTH is -43.41%; over the trailing twelve months it is -29.07%. Its 52-week range spans $0.49 to $3.80. Rallies surfaces HOTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded HOTH stock?
Rallies tracks politician and congressional stock disclosures for HOTH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Knie Robb bought 25.00K (~$16.75K) on Aug 16, 2024.
Knie Robb bought 10.00K (~$3.90K) on Sep 19, 2022.
Knie Robb bought 10.00K (~$4.00K) on Sep 16, 2022.
HOTH Analyst Consensus
HOTH analyst coverage data. Average price target: $0.00.
Common questions about HOTH
Which politicians traded HOTH stock?
Rallies tracks politician and congressional stock disclosures for HOTH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in HOTH?
Yes. Rallies tracks politician and congressional stock disclosures for HOTH, including reported purchases, sales, dates, owners, and trade amounts when available.
Is HOTH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOTH. It does not provide personalized investment advice.